SCHEMBL1379440

SCHEMBL1379440

C=CC[CH]C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid SCHEMBL7144997 0.84 LMNA (0.67)
Bicarbonate SCHEMBL4345305 0.83
Acetic Acid SCHEMBL6063417 0.78
Glycolic Acid SCHEMBL7716253 0.75 TSHR (0.39)
Sulfuric Acid SCHEMBL25293539 0.73 CA5A (0.43)
Urea SCHEMBL3385100 0.73
SCHEMBL8854658 0.73
SCHEMBL13493080 0.73
SCHEMBL5606321 0.73
SCHEMBL29277295 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117065081-A Modified chitosan/Ag nanoparticle composite material and preparation method and application thereof 武汉理工大学 2023-11-17 CN claimed
CN-115803319-A Atropisomers of pyridazinone derivatives as herbicides FMC公司 2023-03-14 CN claimed
EP-3522878-B1 METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA) PROCTER & GAMBLE (US) 2021-03-31 EP claimed
CN-107275720-B Aluminum-air battery electrolyte, aluminum-air battery and manufacturing method thereof 深圳市航盛新材料技术有限公司 2021-01-15 CN claimed
US-10675256-B2 Methods for inhibiting conversion of choline to trimethylamine (TMA) THE PROCTER & GAMBLE COMPANY (US) 2020-06-09 US claimed
EP-3522878-A1 METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA) The Procter and Gamble Company (US) 2019-08-14 EP claimed
US-20190175743-A1 OLIGOMER-BETA BLOCKER CONJUGATES NEKTAR THERAPEUTICS 2019-06-13 US claimed
WO-2019070677-A1 METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA) THE PROCTER & GAMBLE COMPANY (US) 2019-04-11 WO claimed
US-20190099389-A1 METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA) THE CLEVELAND CLINIC FOUNDATION 2019-04-04 US claimed
US-20170360948-A1 OLIGOMER-BETA BLOCKER CONJUGATES NEKTAR THERAPEUTICS 2017-12-21 US claimed
US-4578403-A Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1986-03-25 US claimed
WO-1985004580-A1 PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OR PROPHYLAXIS OF CARDIAC DISORDERS AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1985-10-24 WO claimed
EP-0131006-A4 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES. AMERICAN HOSPITAL SUPPLY CORP (US) 1985-06-06 EP claimed
US-4508725-A BETA-ADRENERGIC BLOCKING AGENTS; GLAUCOMA TREATMENT AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1985-04-02 US claimed
EP-0131006-A1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES. AMERICAN HOSPITAL SUPPLY CORP (US) 1985-01-16 EP claimed
WO-1984002525-A1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES AMERICAN HOSPITAL SUPPLY CORP (US) 1984-07-05 WO claimed
EP-0093155-A4 ESTERS OF ARYLOXYPROPANOLAMINE DERIVATIVES AND USE AS BETA-ADRENERGIC BLOCKING AGENTS. AMERICAN HOSPITAL SUPPLY CORP (US) 1984-04-24 EP claimed
EP-0093155-A1 ESTERS OF ARYLOXYPROPANOLAMINE DERIVATIVES AND USE AS BETA-ADRENERGIC BLOCKING AGENTS. AMERICAN HOSPITAL SUPPLY CORP (US) 1983-11-09 EP claimed
WO-1983001772-A1 ESTERS OF ARYLOXYPROPANOLAMINE DERIVATIVES AND USE AS 'beta'-ADRENERGIC BLOCKING AGENTS AMERICAN HOSPITAL SUPPLY CORP (US) 1983-05-26 WO claimed
US-4244731-A APPLYING A CARBOXY DERIVATIVE OF A 2,6-DIMETHYLPHENOXY COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-01-13 US claimed